Selective neuroimmune modulation by type I interferon drives neuropathology and neurologic dysfunction following traumatic brain injury.

"Declarations Ethics approval and consent to participateAll procedures performed in this study were in accord with protocols approved by the Institutional Animal Care and Use Committee at the University of Iowa. Consent for publicationNot applicable. Competing InterestsThe authors declare they have no competing interests. Competing Interests The authors declare they have no competing interests."

"Funding EAN is supported by the Iowa Neuroscience Institute and the Carver Trust and the National Institutes of Health K08NS110829. AGB is supported by the National Institutes of Health 5P50HD103556. TNJ is supported by the Andrew H. Woods Professorship INI Carver. JTH is supported by the National Institutes of Health R01AI042767, R01AI114543, R01AI167847."